KLA's near-term performance is muted, but the structural growth thesis for 2027 is becoming clearer
AI summary card
KLA's near-term performance is muted, but the structural growth thesis for 2027 is becoming clearer
Morgan Stanley maintains an Overweight rating on KLA Corp and lowers the target price from $274 to $253, believing that while near-term numbers are ordinary, the company is positioned to benefit in 2027 from rising process control intensity, advanced packaging, and leading-edge process investment.
- KLA's September-quarter guidance came in slightly below Morgan Stanley's expectations; near-term results were broadly in line with market expectations and failed to provide a clear catalyst for upward revisions.
- The company raised its 2026 WFE plus advanced packaging market outlook from above $140bn to the low-$150bn range, and indicated a more optimistic scenario in which 2027 WFE could exceed $190bn.
- The 2026 advanced packaging revenue outlook was raised from $1bn to $1.1bn, representing roughly 70% year-over-year growth from $650mn in 2025.
- Morgan Stanley modestly raised its CY27 revenue and EPS forecasts to $20.4bn and $6.23, while its CY28 forecasts were largely maintained at $23.4bn and $7.22.
- The target price reduction stems from the valuation multiple being cut from 38x to 36x, rather than from a deterioration in the core long-term thesis.
Report interpretation
Overview
This report is Morgan Stanley's post-earnings reaction commentary on KLA Corp. The core judgment is a "mixed bag": near-term financial performance and guidance were somewhat muted, explaining the bear case around underperforming WFE in 2026; however, the company's comments on 2027 demand, backlog, leading-edge processes, and advanced packaging strengthened the long-term bull thesis. The report maintains an Overweight rating, but lowers the target multiple due to peer de-rating, reducing the target price from $274 to $253.
Core views
The report's core view is that KLA lacks meaningful near-term upward revision leverage relative to etch and deposition equipment peers, but is positioned to outperform WFE in 2027 through higher process control intensity. The bull thesis is concentrated in CY27: $12.5bn RPO, 1D and 1.4nm nodes, TSMC leading-edge processes, DRAM/HBM, hybrid bonding, and SoIC-related advanced packaging. The bear thesis is concentrated in CY26: product mix is unfavorable to process control intensity, KLA may be a share donor this year, and earnings did not see a clear above-consensus upward revision.
Analysis framework
Morgan Stanley forms its view by combining earnings guidance, WFE and advanced packaging market expectations, company backlog, node transitions, DRAM wafer trends, process control intensity, peer valuation multiples, and CY28 EPS. The target price uses 36x CY28e EPS of $7.22, implying $253; the bull-case scenario uses 40x CY28e EPS of $8.12, implying $325; the bear-case scenario uses 25x CY28e EPS of $6.59, implying $165.
Methodology notes
36x CY28e EPS
The base case uses a valuation of 36x CY28e EPS of $7.22, representing a 15% premium to U.S. SPE peers AMAT and LAM, to reflect KLA's growth prospects in foundry logic and DRAM.
Bull, base, and bear target prices
The report provides a bull-case target price of $325, a base-case target price of $253, and a bear-case target price of $165, corresponding to different assumptions for market share, revenue growth, gross margin, and EPS.
KLA growth relative to WFE
The report links KLA's growth to WFE, leading-edge logic processes, DRAM/HBM, and advanced packaging, and believes KLA will grow 36% in 2027, above WFE's 31%.
Asset mapping & comparison
Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).
- KLA Corp (KLAC.O)Core coverage target
- Strengths
- A leader in process control, benefiting from leading-edge logic nodes, DRAM/HBM, advanced packaging, and customer capacity expansion; high RPO improves visibility into 2027 revenue.
- Weaknesses
- Product mix is unfavorable in 2026, near-term earnings lack a clear beat, and the report believes the company may underperform WFE and give up some share this year.
- Comparison
- Compared with etch and deposition peers, KLA has weaker near-term revision leverage; however, the report believes its long-term growth and gross margin advantages support a premium valuation relative to SPE peers.
- Risks
- A slowdown in leading-edge logic and DRAM investment, foundry plan reductions, share loss in mask inspection or e-beam, and China-related restrictions.
- Advanced Energy Industries Inc. (AEIS.O)Preferred name within the same coverage universe
- Strengths
- The report says it prefers other Overweight names in the near term, including AEIS, because CY27/28 earnings forecasts have seen larger upward revisions.
- Weaknesses
- The disclosed excerpt indicates its valuation multiple trades at a discount to SPE OEMs, partly due to a lower gross margin profile.
- Comparison
- Relative to KLA, AEIS is more attractive in terms of near-term estimate revisions, but it is not the primary subject of this report.
- Risks
- The report excerpt mentions factors such as AMAT/LAM share changes, 800v transition, and changes among data center customers.
- MKS Inc. (MKSI.O)Preferred name within the same coverage universe
- Strengths
- The report says it prefers MKSI in the near term due to larger CY27/28 estimate revisions.
- Weaknesses
- The disclosed excerpt indicates its valuation discount reflects balance sheet concerns and a business mix shift toward packaging.
- Comparison
- Relative to KLA, MKSI is listed as one of the more preferred Overweight names in the near term, but KLA remains a long-term structural bullish name.
- Risks
- Slower WFE growth, NAND capex discipline, weak PC/smartphone/server demand, and slower-than-expected deleveraging progress.
Key data
- RatingOverweightMorgan Stanley maintains an Overweight rating on KLA Corp.
- Target price change$274.00 -> $253.00The target multiple was lowered from 38x to 36x, reflecting peer de-rating.
- Current share price$190.80As of the close on July 28, 2026.
- 2026 WFE + advanced packaging outlooklow-$150bn rangePreviously above $140bn.
- 2026 advanced packaging revenue outlook$1.1bnPreviously $1bn; 2025 was $650mn, implying expected year-over-year growth of about 70%.
- RPO$12.5bnAbove the FY25 year-end level of $7.86bn, providing important visibility for 2027 growth.
- CY27 forecast revision$20.4bn revenue / $6.23 EPSPreviously $20.2bn revenue / $6.12 EPS.
- CY28 base case$23.4bn revenue / $7.22 EPSThe report says the CY28 forecast is broadly unchanged.
- Base-case CY28 revenue growth13.8%The base case assumes KLA modestly increases market share.
- Bull-case target price$325.00Based on 40x CY28e EPS of $8.12.
- Bear-case target price$165.00Based on 25x CY28e EPS of $6.59.
Impact & implications
For investors, the report conveys a cautious near-term but constructive long-term signal. KLA lacks near-term earnings revision leverage relative to peers, which may weigh on valuation and share price performance; however, if 2027 WFE expansion, leading-edge logic investment, DRAM/HBM, and advanced packaging intensity materialize, KLA's process control business could outperform the industry. The target price cut mainly reflects valuation multiple compression rather than a reversal in the long-term fundamental view.
Risks
- KLA may underperform WFE in 2026, and near-term results and guidance failed to materially exceed expectations.
- If leading-edge logic and DRAM investment slow, the thesis of rising process control intensity will weaken.
- If foundries such as Intel and Samsung scale back advanced process plans, KLA's growth outlook will be affected.
- KLA may lose share in mask inspection to Lasertec and in e-beam to AMAT or ASML.
- China-related restrictions may affect revenue and the supply chain.
- Peer de-rating has already reduced the target multiple from 38x to 36x; if the sector continues to de-rate, the target price will remain under pressure.
What to watch
- Whether KLA can meaningfully exceed market expectations in subsequent quarters and drive upward revisions to CY27/28 consensus forecasts.
- Whether 2027 WFE approaches or exceeds the more optimistic expectation of $190bn.
- The capacity expansion pace of TSMC leading-edge processes, 1D and 1.4nm nodes, Intel, Rapidus, TeraFab, and others.
- Whether DRAM/HBM continues to drive higher process control intensity.
- Whether advanced packaging revenue reaches the 2026 target of $1.1bn and continues to grow faster than the market.
- Changes in KLA's market share, especially in process control, mask inspection, and e-beam.
- Whether Overweight equipment-chain names such as AEIS and MKSI continue to receive larger upward revisions to CY27/28 forecasts.